Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Update from the FDA on the continued efforts to mitigate the IV saline and amino acids for injection shortages exacerbated by Hurricane Maria.
read more
During COVID-19, FDA will continue to utilize and implement additional alternative inspection tools and approaches while postponing domestic and foreign routine surveillance inspections.
read more
Wednesday, September 13, 2017
Today, a new and exciting technology – continuous manufacturing (CM) – can truly transform the drug manufacturing process so that it is more reliable and efficient.
read more
The FDA posted warning letters to four companies who produce homeopathic drug products for significant violations of CGMP.
read more
The FDA has issued warning letters to three repackers of API for significant violations of current good manufacturing practice (CGMP) requirements.
read more
Tuesday, October 15, 2019
The FDA has posted a warning letter to Torrent Pharmaceuticals in Ahmedabad, Gujarat, India.
read more
The FDA and the EMA are publishing the discussion and main conclusions from a workshop held on November 26, 2018, at the EMA headquarters in London.
read more
Wednesday, September 02, 2020
The FDA and the FTC has issued a warning letter to Lattice Biologics for marketing an unapproved amniotic fluid product, sometimes referred to as AmnioBoost.
read more
Wednesday, March 11, 2020
The FDA and the FTC issued warning letters to seven companies for selling fraudulent COVID-19 products.
read more
The FDA announced a further expansion of COVID-19 testing options through the recognition that spun synthetic swabs could be used to test patients by collecting a sample from the front of the nose.
read more
Thursday, February 07, 2019
The U.S. District Court for the Western District of Pennsylvania entered a consent decree of permanent injunction between the US and Ranier’s Rx Laboratory and owner/pharmacist Francis H. Ranier.
read more
Tuesday, December 20, 2022
The U.S. District Court for the Western District of Oklahoma entered a consent decree against Qualgen LLC, an outsourcing facility with a history of violations.
read more
Tuesday, October 23, 2018
A federal court ordered a Tennessee-based company to stop selling OTC drug products until the company complies with the Federal Food, Drug, and Cosmetic Act and other requirements listed in a consent decree.
read more
According to the complaint, despite Delta Pharma’s repeated promises to correct deficiencies, Delta Pharma continued to violate the law.
read more
U.S. District Judge Kristine G. Baker for the Eastern District of Arkansas entered a consent decree of permanent injunction today between the U.S. and Cantrell Drug Company of Little Rock, Arkansas, and the company’s Chief Executive Officer and co-...
read more